跳至主要内容
临床试验/NCT04924686
NCT04924686Unknown不适用

A Bacterial Bi-functional Peptidoglycan Hydrolase Sheds NOD2 Ligands to Regulate Gut Homeostasis

Zhujiang Hospital1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2020年5月10日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
600
试验地点
1
主要终点
NOD2 ligands in fecal and plasma

研究概览

简要总结

Nucleotide-binding oligomerization domain 2 (Nod2) signaling is critical for human health.To figure out the clinical relevance of NOD2 ligands, the investigators plan to evaluate the change of NOD2 ligands in inflammatory bowel diseases (IBD), CRC, atherosclerotic cardiovascular disease (ACVD), and type 2 diabetes mellitus (DM2 ).

详细描述

Previous studies have shown that NOD2 gene mutants were associated with the Crohn's disease (CD), colorectal cancer (CRC) and many other diseases, suggesting the critical role of NOD2 signaling in human physiology and pathogenethesis. However, whether decreased NOD2 ligands also contributed to these diseases is unknown. In this study, the investigators plan to evaluate the change of NOD2 ligands in inflammatory bowel diseases (IBD), CRC, atherosclerotic cardiovascular disease (ACVD), and type 2 diabetes mellitus (DM2 ). For each of the patient, a sex- and age- matched control were chosen. Both the targeted metabolomics (LC-MS-MS methods) and NOD2-transfected cells co-expressing NF-κB luciferase reporters were used to test NOD2 ligands in the fecal and plasma samples.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females at least 18-70 years old.
  • Patient able to give informed consent.
  • Patient with biopsy-proven CRC
  • Patient with biopsy-proven Crohn's disease (CD) or ulcerative colitis(UC), in the active phase.
  • patients with clinical diagnosed DM2
  • patients with ACVD:coronary angiography more than 50% stenosis in single or multiple vessels.
  • The age- and sex- matched health controls for each patient.

排除标准

  • 1.Use antibiotics or probiotics within the last 2 weeks.

结局指标

主要结局

NOD2 ligands in fecal and plasma

时间窗: baseline

detected using targeted metabolomics (LC-MS-MS methods) and NOD2-transfected cells co-expressing NF-κB luciferase reporters

次要结局

未报告次要终点

研究者

发起方
Zhujiang Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hongwei Zhou

Proffessor

Zhujiang Hospital

研究点 (1)

Loading locations...

相似试验